Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Cunningham

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Nature Genetics|April 20, 2023
Genetics of myocardial interstitial fibrosis in the human heart and association with diseaseVictor Nauffal, Paolo Di Achille, Marcus D R Klarqvist, et al.
Journal of Cardiac Failure|March 7, 2025
Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection FractionElke Platz, Kirsty McDowell, Deepak K Gupta, et al.
Circulation. Heart Failure|November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical TrialsPablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
ESC Heart Failure|June 23, 2022
Pharmacogenomic study of heart failure and candesartan response from the CHARM programmeMarie-Pierre Dubé, Olympe Chazara, Audrey Lemaçon, et al.
Circulation. Heart Failure|February 23, 2026
Artificial Intelligence-Enabled ECG Analysis to Predict Incident Heart FailureShaan Khurshid, Samuel F Friedman, Shinwan Kany, et al.
Circulation|August 26, 2023
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER TrialSafia Chatur, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure|April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
JAMA Cardiology|February 26, 2025
Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialJonathan W Cunningham, Safia Chatur, Brian L Claggett, et al.
European Journal of Heart Failure|May 22, 2023
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trialSafia Chatur, Jonathan W Cunningham, Muthiah Vaduganathan, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Nature Genetics|April 20, 2023
Genetics of myocardial interstitial fibrosis in the human heart and association with diseaseVictor Nauffal, Paolo Di Achille, Marcus D R Klarqvist, et al.
Journal of Cardiac Failure|March 7, 2025
Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection FractionElke Platz, Kirsty McDowell, Deepak K Gupta, et al.
Circulation. Heart Failure|November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical TrialsPablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
ESC Heart Failure|June 23, 2022
Pharmacogenomic study of heart failure and candesartan response from the CHARM programmeMarie-Pierre Dubé, Olympe Chazara, Audrey Lemaçon, et al.
Circulation. Heart Failure|February 23, 2026
Artificial Intelligence-Enabled ECG Analysis to Predict Incident Heart FailureShaan Khurshid, Samuel F Friedman, Shinwan Kany, et al.
Circulation|August 26, 2023
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER TrialSafia Chatur, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure|April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
JAMA Cardiology|February 26, 2025
Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialJonathan W Cunningham, Safia Chatur, Brian L Claggett, et al.
European Journal of Heart Failure|May 22, 2023
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trialSafia Chatur, Jonathan W Cunningham, Muthiah Vaduganathan, et al.
Pageof 8